FDA approves 'breakthrough' Parkinson's treatment led by Cleveland Clinic doctor

Дата публикации: 28-09-2026 20:55:10

On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical to those living with the disease.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA	0	6.94	28-04-2026
2	European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease	0	7.44	26-09-2026
3	GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH	0	6.94	27-04-2026
4	Минздрав утвердил новый стандарт лечения депрессии у взрослых россиян	0	7.97	27-09-2026
5	GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study	0	8.6	27-09-2026
6	GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study	0	8.6	27-09-2026
7	GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study	0	8.6	27-09-2026
8	GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study	0	8.6	27-09-2026
9	Dopamina	0	11.77	28-09-2026
10	A new treatment has been approved for extensive-stage small cell lung cancer	0	7.66	24-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.58. Источник: www.wkbn.com.